Currently out of the existing stock ratings of Richard Newitter, 229 are a BUY (55.45%), 182 are a HOLD (44.07%), 2 are a SELL (0.48%).

Richard Newitter

Work Performance Price Targets & Ratings Chart

Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 71.16% that have a potential upside of 22.47% achieved within 193 days.

Richard Newitter’s has documented 840 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BSX, Boston Scientific Corp at 18-Dec-2024.

Wall Street Analyst Richard Newitter

Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 4/21/2021. The price target of $286.67 was fulfilled within 1 day with a profit of $10.46 (3.52%) receiving and performance score of 35.2.

Average potential price target upside

of $47.52 (28.38%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $30.14 (17.17%) on BDX (BECTON DICKINSON AND COMPANY).
of $28.75 (14.2%) on ISRG (INTUITIVE SURGICAL).

ALC Alcon AG ALGN Align Technology AXGN Axogen BDX Becton Dickinson and Company GMED Globus Medical HOLX Hologic INSP Inspire Medical Systems ISRG Intuitive Surgical ITMR Itamar Medical Ltd LNTH Lantheus Holdings NUVA NuVasive SIEN Sientra SYK Stryker TFX Teleflex orporated XENT Intersect ENT ZBH Zimmer Biomet Holdings AXNX Axonics Modulation Technologies CNMD CONMED IART Integra LifeSciences Holdings MDT Medtronic PLC WMGI Wright Medical Group N.V EW Edwards Lifesciences Corp NARI Inari Medical SPNE SeaSpine Holdings Corp BSX Boston Scientific Corp KIDS Orthopediatrics Corp NVRO Nevro Corp PRCT Procept Biorobotics Corp TMCI Treace Medical Concepts

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

David Saxon (NEEDHAM)